Discover More:
Brewing thoughts: green tea and liver injury
With growing concerns about the availability of medical appointments and medicines in these days of COVID-19, people are relying more and more on dietary supplements to support their health. According to IRI – a market research firm that tracks U.S.
Building a More Resilient Supply Chain Requires Transparency, Diversity, and Collabo...
I was pleased to address the American Association of Pharmaceutical Scientists (AAPS) on May 12 during a webinar focused on the impact of the COVID-19 pandemic on the supply of quality medicines.
Caring for COVID-19 patients – Will we have access to enough safe, quality medicines?...
As the impact of the COVID-19 pandemic continues to unfold, each day brings to light new realizations of just how interconnected, and sometimes vulnerable, the global supply chain for medicines is.
How USP Panel and Expert Committee members help create better standards: A personal p...
To those in the pharmaceutical industry, USP may be both familiar and a little mysterious. We’re all aware that USP documentary and reference standards help ensure the quality of medicines in the United States and around the world.